OptraSCAN receives US FDA 510(k) clearance for digital pathology system Clearance covers integrated pathology system for HER2 assessment in clinical practice
Biocartis Group partners with Immunexpress For co-commercialisation agreement for SeptiCyte RAPID Test for use on Biocartis’ fully automated molecular diagnostics platform…
